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Abstract 
Advances of modern sensing and sequencing technologies generate a deluge of high dimensional space-
temporal physiological and next-generation sequencing (NGS) data. Physiological traits are observed 
either as continuous random functions, or on a dense grid and referred to as function-valued traits. Both 
physiological and NGS data are highly correlated data with their inherent order, spacing, and functional 
nature which are ignored by traditional summary-based univariate and multivariate regression methods 
designed for quantitative genetic analysis of scalar trait and common variants. To capture morphological 
and dynamic features of the data and utilize their dependent structure, we propose a functional linear 
model (FLM) in which a trait curve is modeled as a response function, the genetic variation in a genomic 
region or gene is modeled as a functional predictor, and the genetic effects are modeled as a function of 
both time and genomic position (FLMF) for genetic analysis of function-valued trait with both GWAS 
and NGS data. By extensive simulations, we demonstrate that the FLMF has the correct type 1 error rates 
and much higher power to detect association than the existing methods. The FLMF is applied to sleep 
data from Starr County health studies where oxygen saturation were measured in 22,670 seconds 
on average for 833 individuals. We found 65 genes that were significantly associated with 
oxygen saturation functional trait with P-values ranging from 2.40E-06 to 2.53E-21. The results 
clearly demonstrate that the FLMF substantially outperforms the traditional genetic models with 
scalar trait. 
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Introduction 
Physiological traits such as electrocardiogram (ECG), phonocardiogram (PCG), 
seimocardiography (SCG), and oxygen saturation levels provide important information on the 
health status of humans and can be used to monitor, diagnose and manage diseases. For example, 
ECG is a measurement of the electrical activity of the heart muscle obtained from the surface of 
skin. It measures the rate and regularity of heart beats. ECG is the most commonly performed 
cardiac test and of great clinical value.1 It provides valuable information on the biological 
processes and current state of the heart, and can be used for diagnosis of arrhythmias2,3 , 
myocardial infarction and other cardiovascular diseases4. Oxygen saturation level which are 
proportional to the reduction in airflow cause total or partial reduction in respiration of the Sleep 
Apnea-Hypopnea Syndrome (SAHS) during sleep.5 SAHS is a risk factor for cardiac and 
cerebral infarct, high arterial pressure, arrhythmias, and in general, several dysfunctions of the 
cardiorespiratory system. The physiological traits can be described as a mathematical function of 
time t  or other indexes which are often referred to as function-valued traits.6 
Although many physiological traits are measured as a function, the widely used methods for 
genetic studies of physiological traits in humans are the same as that for the traditional single-
valued quantitative traits where a single number is taken as a quantitative trait. These methods 
use summary statistic to measure or represent physiological traits. For example, heart rate (HR), 
the P-R interval, QRS complex duration, QT, and QTc interval are often used as a trait in genetic 
analysis of ECG.7-9 Physiological traits are time dependent and dynamic in nature. They are 
repeatedly measured at multiple time points and often described by functions or curves.  The 
temporal pattern of genetic control for physiological traits should be compared across different 
stages of development.10 To capture the morphological shape and dynamic features of the 
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physiological traits, methods that analyze all dynamic time points (traits) jointly and are often 
referred to as function valued QTL analysis have recently developed.11,12 Quantitative genetic 
analysis of function-valued traits enhance our understanding the genetic control of the whole 
dynamic process of the traits and  improve the statistical power to detect QTL. They explore the 
inherent order, spacing and functional nature of the data often ignored by traditional marginal 
genetic models.13 
Although the genetic study of quantitative traits has been widely performed and experienced 
extensive technical development, the quantitative genetic analysis of function-valued trait is 
comparatively less development.14  To our knowledge, no statistical methods have been 
developed for genetic analysis of function-valued traits with next-generation sequencing (NGS) 
data. In the past few years we have witnessed the rapid development of novel statistical methods 
for association studies using NGS data.15-19  But, these methods might not be appropriate for 
genetic analysis of function-valued trait. The quantitative genetic analysis of rare variants for 
function-valued trait remains challenging. To meet the challenge, we propose the function linear 
model with functional responses and functional predictors (FLMF) for quantitative genetic 
analysis of function-valued traits with NGS data. In the FLMF, the time varying values of 
physiological trait are taken as a functional response and the genotype profile across a genomic 
region or a gene can be modeled as a function of genomic location. The FLMF has several 
remarkable features. First, the FLMF accounts for the continuous change in traits and preserves 
the intrinsic structure and all the positional-level genetic information. Second, the FLMF 
simultaneously utilize both correlation information among the trait at different times and among 
all variants in a genomic region. Third, the multicolinearity problems in the FLMF which may be 
presented in both trait and genetic variation is alleviated. Forth, the FLMF expand both trait 
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function and genotype function in terms of orthogonal eigenfunction, which lead to substantial 
dimension reduction.  
To evaluate its performance for genetic association analysis of function-valued trait, we use large 
scale simulations to calculate the type I error rates of the FLMF for testing the association of a 
genomic region (gene) with the function-valued trait.  We evaluate the power of six statistical 
models. For the time course trait data, we considered the FLM with both trait function and 
genotype function, the multiple linear model for multiple phenotypes and simple regression for 
multiple phenotypes. For the cross-sectional data, we considered the FLM with scalar trait and 
genotype function, multiple linear model for single phenotype and simple regression for single 
phenotype. To further evaluate its performance, the FLMF is applied to oxygen saturation studies 
in Starr County, Texas where a total of 35,280 measurements were taken over a night and a total 
of 406,299 SNPs in 22,670 genes was typed for 833 individuals with Mexican Americans origin   
from Starr County. A program for implementing the developed FLMF for quantitative genetic 
analysis of function-valued trait can be downloaded from our website 
http://www.sph.uth.tmc.edu/hgc/faculty/xiong/index.htm  
Material and Methods 
Functional linear models with both functional response and predictors for genetic studies 
of temporal or space quantitative Trait 
   For the convenience of discussion, temporal or space trait is referred to as a functional trait. 
We consider a temporal trait ],0[ ),( Tttyi  of the i -th individual which varies in time and a 
genomic region (or gene) ],[ ba . Let be a genomic position in the region ],[ baS  . Define a 
genotype profile )(sX i   of the i-th individual as 
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where M and m are two alleles of the marker at the genomic position s , )(sPM and )(sPm are the 
frequencies of the alleles M and m, respectively. A functional linear model with both functional 
response and predictors is defined as  
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Since equation (2) should hold for all t , we must have 
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The model (3) is a standard linear model. Instead of using the observed data as the values of the 
response and predictor variables, we use their expansion coefficients as the values of the 
response and predictor variables in the linear model (3). Equation (3) can be further written in a 
matrix form: 
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The least square estimates of the parameter vector   is given by 
.)(ˆ 1 YAAA TT           (5) 
Using equation (5) we obtain the genetic additive effect function: 
)()(),( tBsts T   .         (6) 
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Test Statistics 
An essential problem in genetic studies of the functional quantitative trait is to test the 
association of a genomic region with the functional quantitative trait. Formally, we investigate 
the problem of testing the following hypothesis: 
  0),(:0 tsH  ,       tSs  ,                                                     (7) 
against 
  0),(: tsHa  . 
If the genetic effect function ),( ts  is expanded in terms of the basic functions: 
 )()(),( tBsts T   , 
then, testing the null hypothesis H0 in equation (7) is equivalent to testing the hypothesis: 
  0:0 BH .                                                                                      (8) 
To derive the test statistic, we first calculate variance of the estimated expansion coefficient 
matrix of the genetic additive effect function. Let vec denote the vector operation. Then, from 
equation (5), we have 
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Variance ul can be estimated by 
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Let  
)ˆ(ˆ Bvecb  and  be the matrix that are obtained from the last  kk y row and kk y columns of 
the matrix ))ˆ(var( vec . We can define the following statistic for testing the association of a 
genomic region with the functional trait: 
bbT TF
ˆˆ 1 .          (14) 
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Under the null hypothesis of no association, the statistic 
FT  will be distributed as a central 
2
)( 
 kk y
distribution. 
Results 
Null Distribution of Test Statistics  
In the previous section, we have shown that the test statistics 
FT  are asymptotically 
distributed as a central 2
)( 
 kk y distribution. To examine the validity of this statement, we 
performed a series of simulation studies to compare their empirical levels with the nominal ones.   
We calculated the type I error rates for rare alleles, and both rare and common alleles. We 
assumed the following model to generate a functional quantitative trait for type 1 error 
calculations: 
)()( jiji tty   , 
where  )( ji ty  is the trait value of 𝑖
𝑡ℎ individual at the time jt ,   is a constant for all i  and jt , 
)( ji t  is the error term of 𝑖
𝑡ℎ individual at the time jt , and this error term is generated by 
independent standard Brownian motion.  
     We first considered both common and rare variants, i.e., entire allelic spectrum of variants. 
We generated 1,000,000 chromosomes by resampling from 2,225 individuals with variants in 
five genes (CDC2L1, GBP3, IQGAP3, TNN, ACTN2) selected from the NHLBI’s Exome 
Sequencing Project (ESP) . The five genes included 461 SNPs. The number of sampled 
individuals from populations of 1,000,000 chromosomes ranged from 1,000 to 2,000. The time 
points taking trait measurement for type 1 error calculations were 15, 20, 30 and 40. A total of 
5,000 simulations were repeated.  Tables 1 and 2 summarized the average type I error rates of the 
test statistics for testing the association of rare variants (MAF < 0.05) and all common and rare 
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variants over five genes, respectively, at the nominal levels α=0.05, α=0.01 and α=0.001. Tables 
1 and 2 showed that in general, the type I error rates of the test statistics in the functional 
quantitative trait analysis were not appreciably different from the nominal alpha levels.  
Power Evaluation 
To evaluate the performance of the functional linear models with both functional response and 
predictors for testing the association of a genomic region with a functional quantitative trait, we 
used simulated data to estimate their power to detect a true association. A true functional 
quantitative genetic model is given as follows. Consider L trait loci that are located at the 
genomic positions
Lss ,...,1 .  Let sA  be a risk allele at the 
ths  trait locus.  Let jt be the j -th time 
point when the trait measurement is taken. The following multiple linear regression is used as an 
additive genetic model for a quantitative trait:  
)()()(
1 jij
L
s sisji
ttbxty     , 
where )( ji ty is the trait value of 𝑖
𝑡ℎ individual measured in the time jt ,  is an overall mean, isx
is an indicator variable for the genotype of 𝑖𝑡ℎ individual at the ths trait locus, )( js tb is the 
genetic additive effect of the SNP at the 
ths trait locus and the time jt , the error term )( ji t is 
generated by independent standard Brownian motion process. The genetic effect )( js tb is 
modeled as )()( jsjs tbbtb  , where 
t
j etb
610)(  . We considered four genetic models for sb : 
additive, dominant, recessive and multiplicative. The relative risks across all variant sites are 
assumed to be equal and the variants were assumed to influence the trait independently (i.e. no 
epistasis).  Let 10 f  be a baseline penetrance that is defined as the contribution of the wild 
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genotype to the trait variation and r  be a risk parameter. The genetic additive effects for the four 
trait models are defined as follows:  
dominant model: 0)1)(1( frPb ss  , recessive model: ,)1( 0frPb ss   
additive model: 0)1( frPb ss   and multiplicative model: 0)1)(1( frPrPb sss  , where   
sP is the frequency of the risk allele located at the genomic position s .  
     For power comparisons, we also consider cross-section trait models.  The genetic effects for 
the cross-section trait models is defined as average of the genetic effect function over the time 
where the phenotype values were measured at 20 time points: )( medss tbbb  , where )( medtb is the 
median of the function of 20,...,1),( jtb j . The trait value for the cross-sectional model is 
generated by 
i
L
s sisi
bxy    1 . 
     We generate 100,000 individuals by resampling from 2,225 individuals of European 
origin with variants in gene TNN (88 rare variants and 18 common variants) selected from ESP 
dataset. We randomly selected 10% of the variants as risk variants. A total of 1,000 individuals 
for the dominant, additive and multiplicative trait models and 2,000 individuals for the recessive 
trait model were sampled from the populations. A total of 1,000 simulations were repeated for 
the power calculation.  We compared the power of six methods. For the time course trait data, we 
considered the FLM with both trait function and genotype function, the multivariate regression 
for multiple phenotypes and simple regression for multiple phenotypes. For the cross-sectional 
data, we considered the FLM with scalar trait and genotype function, multivariate regression for 
single phenotype and simple regression for single phenotype.  
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We compare the power curves of FLM with cross-sectional model, Multivariate Regression 
Model and Simple Linear Regression Model in this study. We repeat 1,000 simulations for all 
the comparisons. Also, we assuming that all variances are independently and equally influence 
the trait. That is we assume there are no interactions happen in those variances.  
Figures 1, 2 and Supplementary Figures 1 and 2 plot the power curves of six statistic models: the 
functional linear model with both functional response and predictors for function-valued trait 
(FLMF), the multiple linear model for function-valued trait (MLMF), the simple regression 
model for function-valued trait (SRGF), the functional linear model with scalar response and 
functional response for cross section marginal genetic model (FLMC), multiple linear model for 
cross section marginal genetic model and simple regression for cross section marginal genetic 
model (SRGC) for testing association of  rare variants  in the genomic region under dominant, 
additive, multiplicative, and recessive models, respectively. These power curves are a function of 
the risk parameter at the significance level 05.0 . Several features emerged from these figures. 
First, the power of the FLMF was the highest. Except for the recessive models, the FLMF could 
still detect association of a gene with the function-valued trait even using sample sizes of 1,000. 
Second, power difference between the FLMF and other five models was substantial. Third, the 
power of simple regression for both function-valued trait and cross section marginal model 
(SRGF and SRGC) was extremely low. In most scenario, the simple regression had not power to 
detect association. Forth, in general, the power of tests using function-valued approach was 
higher than that using traditional cross section approach.  
Now we study the power of six models for testing the association of both common and rare 
variants. Figures 3 and 4, and Supplementary Figures 3 and 4 plotted the power of six models  
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for testing association of 18 common variants and 88 rare variants  in the genomic region as a 
function of the risk parameter  at the significance level 05.0 under the additive, 
multiplicative, dominant and recessive models, respectively. Again, we observed the same 
pattern of their power for testing association of all common and rare variants as that for testing 
association of rare variants. The power of all statistics under additive model was higher than that 
under other three trait models. Also, we observed that when risk parameter exceeds 1.6 the 
power of the FLMC and MLMC was higher than the power of MLMF. In any scenarios, the 
FLMF had the highest power to detect association among six models. This demonstrated that the 
FLMF can be our best choice in quantitative trait association studies no matter whether the 
variants are common or rare. As we expected, the power of the tests for both common and rare 
variants was higher than that for testing association of rare variant only.  
Application to Real Data Examples 
     To further evaluate its performance, the FLMF was applied to oxygen saturation studies in 
Starr County, Texas. The oxygen saturation signals were measured by seconds. A total of 35,280 
measurements were taken over a night. Oxygen saturation provides important information on the 
sleep quality of the obstructive sleep apnea.20 A total of 406,299 SNPs in 22,670 genes was typed 
for 833 individuals with Mexican Americans origin from Starr County. Since the FLMF requires 
to expand genotype function in terms of eigenfunction, which need to have at least 3 SNPs in the 
gene, we excludes the gene with only one or two SNPs in it. The left total number of genes for 
analysis was 17,258. Therefore, the P-value for declaring significance after applying the 
Bonferroni correction for multiple tests was
61090.2  . Distributions of gender, age, sleeping 
time and BMI were summarized in Table S1. To reduce the number of measurements included in 
the analysis, we used the mean of the oxygen saturation in every 10 seconds as the trait values. 
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SNPs in 5kb flanking region of the gene are assumed to be belong to the gene. To ensure the 
numerical stability, we used single value decomposition to calculate the inverse of the matrix.21 
We selected the number of single values such that it can account for 99% of total variation.  
To examine the behavior of the FLMF, we plotted QQ plot of the test (Figure 5) where P-
values were calculated after adjusting for sex, age and BMI in the model. The QQ plots showed 
that the false positive rate of the FLMF for detection of association with oxygen saturation trait is 
controlled. In total, we identified 65 genes that were significantly associated with oxygen 
saturation function-valued trait with P-values ranging from  
6104.2   to 21105.2  (Table 3). 
Instead of using whole oxygen saturation curve as functional response, we also used their mean 
as scalar response variable and applied the FLMC for testing association. In Table 3, we included 
the P-values of using the FLMC for testing association of a gene with the mean oxygen 
saturation overnight. To compare with other methods for association analysis of function-valued 
traits, we provided Table S2 in which we also listed minimum of P-values of 65 significant genes 
over all observed time period which were calculated using MLM and SRG for each time point.   
    Several remarkable features were observed from this real data analysis. First, the FLMF 
utilizes the merits of taking both phenotype and genotype as functions. It decomposes time 
varying phenotype function into orthogonal eigenfunctions of time and position varying 
genotype function into orthogonal eigenfunctions of genomic position. The FLMF reduces the 
dimensions due to both phenotype variation and genotype variation (only a few eigenfunctions 
are used to model variation), which in turn increases statistical power of the test.  Table 3 clearly 
demonstrated that P-values calculated by the FLMF were much smaller than that by the FLMC. 
The models for genotype variation within a gene for the FLMF and FLMC are the same. Only 
difference between the FLMF and FLMC is how to model the phenotype. The FLMF model the 
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phenotypes as curve or function while the FLMC models the phenotypes as its mean or a scalar. 
This real data example showed that the function-value (time course data) approach can achieve 
much stronger significance than the scalar value (cross section study) approach. Second, to 
further illustrate that the function-valued statistical methods can be more powerful than the 
traditional quantitative genetic analysis, we presented Table S2 showing that the P-values of the 
FLMF were smaller than the minimum of P-values of the MLM and SRG over all observed time 
interval at night.  Third, genetic variants in a gene might make only mild contribution to the 
oxygen saturation variation at individual time point, these genetic variants may show significant 
association with the oxygen saturation curve as shown in Figure S5 where the P-value for testing 
the association of gene ANKLE1 with the oxygen saturation curve using the FLMF was 
141051.2   and the P-values for the tests using the MLM at the individual time point ranges 
from 
71052.6  to 0.9265. There were a total of 3,528 time points. We observed a total of 188 
time points with P-value < 0.05 when using the MLM to test association at the individual time 
points. None of the 3,528 tests showed strong evidence of association, but indeed we observed 
strong association of the gene ANKLE1 with the oxygen saturation curve due to using all 
information about correlation and continuity of underlying structure of phenotype function.  
Fourth, unlike traditional quantitative genetic analysis where a single constant P-value for the 
test is calculated, in the genetic analysis of function-valued trait we can observe the time varying 
P-values. To illustrate this, we plotted Figure S6 showing the P-values of the MLMT for testing 
the association of all SNPs within the gene TMEM50B with the oxygen saturation at each time 
point over night as a function of time t .There was the rapid changes of P-value of the MLM test 
over time. We observed two peaks showing significant association with the oxygen saturation. 
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At most times during the night the genetic variation in the gene TMEM50B did not have big 
impact on the variation of the oxygen saturation. 
The genetic effect in the FLMF is characterized by its spatiotemporal pattern. The genetic 
effect is a function of both time t  and genomic position s . Similar to the concept of probability 
density function in the probability theory, the genetic effect function is viewed as the average 
genetic effect in a unit interval of time (or index value) and the genomic region. The genetic 
effect function is more interpretable than the scattered spatiotemporal genetic effect points of the 
SNPs within the gene. It often consists of several peaks and valleys where the values at the peak 
of the genetic effect function are the synthesized genetic effects of the individual SNPs in the 
region due to the correlation between the peak and nearby time and SNPs. To illustrate this, we 
plotted Figure 6 showing the genetic effect function ),( ts of the gene TMEM50B (P-value <
91059.9  ) as a function of time and the genomic position in the FLMF model. The genetic 
effect function surface ),( ts  provide full and detailed spatiotemporal information on how and 
what genetic variants affect the development of biological process, which will lead to new 
biological insight.  
Among 65 significant genes, five genes RELB, MAFF, EEF1A1, CDC42EP5 and COMMD7 
are involved in pro-inflammatory NF-kB signaling pathway.23-27 Pro-inflammatory NF-kB 
signaling pathway plays an important molecular role in linking between sleep apnea, obesity, and 
inflammation. Targeting the NF-κB pathway will ameliorate the metabolic dysregulation 
involved in obstructive sleep apnea (OSA).28 OSA is associated with increased risk of 
development of obesity, hypertension, diabetes and heart diseases. It was reported that genes 
GIPC1, LYRM1, LHX2 and RELB were associated with obesity,29-32  genes EEF1A1 and GFP1 
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were involved in diabetes,33-35 and genes GIPC1, TMEM57, GGT1, LDLRAP1, COMMD7,TPM4 
played an important in heart disease.36-40  
 
Discussion 
The current paradigm for genetic studies of physiological trait is summary-based quantitative 
genetic analysis where function-valued phenotypes are represented as summary statistics. 
However, physiological traits are repeated measurements of dynamic biological processes and 
best to be represented as a mathematic function. Summary statistics cannot capture 
morphological and dynamic features of physiological traits. Summary-based statistical methods 
for quantitative genetic analysis of physiological traits are lack of power to detect association of 
genetic variants with the whole biological process. To overcome the limitations of summary-
based statistical approaches, the function-valued methods for quantitative genetic analysis have 
rapidly developed recently. Although they use the time order and spacing of the data and take 
continuous change in traits of interests into account, these function-valued methods for 
quantitative genetic analysis which are mainly designed for common variants, test association 
variant by variant and do not use order and spacing information of the genomic data. The current 
function-valued methods for genetic analysis which only model the traits as a mathematical 
function, but still model the genetic variant variation as univariate or multivariate variables are 
not well suited for quantitative genetic analysis of physiological traits with NGS data. To address 
the critical barriers in genetic analysis of function-valued trait, we proposed function linear 
models with both phenotype function and genotype function for quantitative genetic analysis of 
physiological traits with NGS data where we not only model the trait as a function, but also 
model the genetic variation across a genomic region as a function. We take a genomic region or a 
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gene as a basic unit of analysis and collectively test the association of a genomic region or gene 
with a function-valued trait. By large simulations and real data analysis we demonstrate the 
merits and limitations of the proposed new paradigm of association analysis for function-valued 
trait. 
 The new approach uses both all trait information in the measured time interval and all genetic 
information in the genome region to collectively test association of all genetic variants within the 
regions with function-valued trait. In the FLMF model, we first separately expand the trait 
function in an interval and the genotype function in a genomic region (gene) in terms of 
orthonormal basis functions. The trait morphological and dynamic information across the time 
interval and  genetic information across all variants in the genomic region including all single 
variant variation and their linkage disequilibrium are compressed into sets of expansion 
coefficients, one for the trait values and one for the genotype values. These expansion 
coefficients in the functional data analysis are referred to as functional principal component 
scores (FPC scores). The multivariate multiple regression is used to model the relationships 
between the FPC scores for the trait function and FPC scores for the genotype function. We use 
the compressed genetic information to globally test association of the genomic region or the gene 
with the function-valued trait.  The FLMF is a natural extension of multivariate multiple 
regression. By large simulations and real data analysis, we showed that the proposed FLMF 
substantially increased the power and dramatically reduced the data noises.  
The most widely used statistical methods for genetic studies of function-valued trait are 
originally designed for testing association of common variants with the function-valued traits. 
They are lack of power to test association of rare variants. The developed FLMF can efficiently 
test the association of the entire allelic spectrum of variants with function-valued trait.  
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Unlike simple and multiple regressions discarding a large amount of information due to using 
limited numbers to summarize the data, the FLM F preserves the intrinsic correlation structure in 
the trait and all the positional-level genetic information. The space-ordering of the trait dynamics 
and genetic variation data is a central feature in the FLMF. Both the neighboring trait values and 
genetic variants are linked. The trait value at one time point depends on the trait values at nearby 
time points. Similarly, the genotypes at one SNP are dependent on the genotypes at nearby SNPs. 
The most popular genetic analysis methods of function-valued trait will not account for the 
space-ordering of the data. The FLMF simultaneously employs individual trait values and their 
correlation, and genetic information of the individual variants and correlation information (LD) 
among all variants. It uses intrinsic functional dependence structure of the data and all available 
trait values in the time interval of interest and genetic information of the variants in the genomic 
region.  
The genetic effect of function-valued trait is a function of time and genomic position of the 
SNP. It changes over time and genomic position. We observed its multiple peaks and valleys to 
indicate that there are specific SNPs showing significant association at particular times. 
Traditional summary-based univariate or multivariate regression analysis will smooth peaks and 
valley and hence lose power to detect association. Our real data analysis clearly demonstrates 
that a set of SNPs will jointly show strong association with function-valued trait, but they 
individually and at individuate time make only mild contribution to the association. 
The trait values in a time interval and genetic variant data in a genomic region which often 
have strong correlation generate multicolinearity and high dimensionality which other methods 
are often unable to deal with efficiently. In the FLMF, the trait function and the genetic variant 
functions  are expended in terms of orthogonal or closely to orthogonal functions. The 
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component coefficients in the expansion will, in general, not be linearly dependent. Therefore, 
the multicolinearity problem in the FLMF is alleviated. 
Different numbers of measurements of trait values at different time points and genotype at 
different genomic position exist for each individual. The FLMF use these data to fit the curves 
that are used to test association, despite the sampling differences among individuals. Therefore, 
the FLMF can efficiently deal with missing data which often happen for the function-valued 
traits and NGS data. 
Although the genetic analysis of function-valued traits has remarkable feature it suffers severe 
limitations due to the cost of additional measurements and unfamiliarity with function data 
analysis. The advances of current wireless and communication technologies facilitate a new 
generation of unobtrusive, portable, and ubiquitous health monitoring systems such as wearable 
ECG and other physiological sensors for continuous patient assessment and more personalized 
health care.41 Cheap wearable and wireless sensors and a Personalized Wearable Monitoring 
System will generate rich physiological datasets (function-valued datasets).  We can expect that 
more and more genetic studies of physiological (function-valued) traits will be performed in the 
near future.  
      Next-generation sequencing technologies will identify ten millions of genetic variants 
across the human genome and modern sensors will generate hundreds of thousands or even 
millions of values of physiological trait. Such extremely high-dimensional data that are full of 
noise and missing data pose fascinating statistical and computational challenges in genetic 
analysis of physiological traits. Transition of analysis from low dimensional data to extremely 
high dimensional data demands changes in statistical methods from multivariate data analysis to 
functional data analysis. In the past decade we have witnessed the emergence of the functional 
22 
 
data analysis as an exciting research area of statistics which provides powerful and informative 
tools for the analysis of various types of high dimensional data including both physiological trait 
variation and genomic variation. Our theoretic results, real oxygen saturation genetic data 
analysis and simulations showed that the FLMF for genetic analysis of function-valued trait is 
able to fully explore all of the information contained in the phenotype and genotype data, 
efficiently utilize the merits of both point-by-point and joint analyses while overcome their 
limitations. Therefore, the FLMF is one of the choices in quantitative genetic analysis with NGS 
data. Emergence of sensing, wireless communication and sequencing technology, and 
application of the genomic continuum model and functional data analysis is expected to open a 
new era for quantitative genetic studies. The results in this paper are preliminary. The purpose of 
this paper is to stimulate further discussions regarding great challenges we are facing in the 
quantitative genetic studies of high dimensional phenotypic and genomic data produced by 
modern sensors and next-generation sequencing. 
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Web Resources 
A program for implementing the developed FLMF for quantitative genetic analysis of function-
valued trait can be downloaded from our website 
http://www.sph.uth.tmc.edu/hgc/faculty/xiong/index.htm  
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Figure Titles and Legends 
Figure 1. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of  rare variants  in the genomic region under dominant model at 
the significance level, assuming a baseline penetrance of 1 and sample sizes of 1,000. 
Figure 2. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of  rare variants  in the genomic region under additive model at 
the significance level, assuming a baseline penetrance of 1 and sample sizes of 1,000. 
Figure 3. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
30 
 
(SRGC) for testing association of  both common and rare variants  in the genomic region under 
dominant model at the significance level, assuming a baseline penetrance of 1 and sample sizes 
of 1,000. 
Figure 4. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of  both common and rare variants  in the genomic region under 
additive model at the significance level, assuming a baseline penetrance of 1 and sample sizes of 
1,000. 
Figure 5. QQ plot for P-values to test the association of 17,258 genes with the oxygen saturation 
function trait by the FLMF where x axis represents the expected –log10 (P-value) and y axis 
represents the observed –log10 (P-value).  
Figure 6. The genetic effect of the gene TMEM50B as a function of time and the SNP located 
genomic position in the FLMF model. 
 
 
 
 
 
 
31 
 
Supplementary Figures 
Figure S1. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of  rare variants  in the genomic region under multiplicative 
model at the significance level, assuming a baseline penetrance of 1 and sample sizes of 1,000. 
Figure S2. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of  rare variants  in the genomic region under recessive model at 
the significance level, assuming a baseline penetrance of 1 and sample sizes of 2,000. 
Figure S3. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
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(SRGC) for testing association of  both common and rare variants  in the genomic region under 
multiplicative model at the significance level, assuming a baseline penetrance of 1 and sample 
sizes of 1,000. 
Figure S4. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of both and  rare variants  in the genomic region under recessive 
model at the significance level, assuming a baseline penetrance of 1 and sample sizes of 2,000. 
Figure S5. –log10 P-value of the MLM for testing the association of gene ANKLE1 with the 
oxygen saturation at each time point overnight as a function of time t  where the redline indicates 
the P-value declaring significance. 
Figure S6. –log10 P-value of the MLM for testing the association of gene TMEM50B with the 
oxygen saturation at each time point overnight as a function of time t  where the redline indicates 
the P-value declaring significance. 
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Table 1. Average type 1 error rates of the statistics for testing association of a gene that consists 
of rare variants, MAF < 0.05, with a function quantitative trait over 5 genes.    
Time Sample Size 0.001 0.01 0.05  
 1000 0.00156 0.01232 0.05640  
 1250 0.00088 0.01032 0.05320  
15 1500 0.00120 0.01264 0.05428  
 1750 0.00152 0.01296 0.05484  
  2000 0.00148 0.01144 0.05492  
 1000 0.00108 0.01164 0.05856  
 1250 0.00088 0.01272 0.05876  
20 1500 0.00088 0.01152 0.05152  
 1750 0.00144 0.01056 0.05508  
  2000 0.00088 0.01068 0.05220  
 1000 0.00136 0.01200 0.05560  
 1250 0.00112 0.01108 0.05232  
30 1500 0.00092 0.01032 0.05108  
 1750 0.00136 0.01032 0.05204  
  2000 0.00084 0.01020 0.05116  
 1000 0.00116 0.01184 0.05612  
 1250 0.00128 0.01048 0.05344  
40 1500 0.00124 0.01144 0.05228  
 1750 0.00096 0.01032 0.04876  
  2000 0.00112 0.01100 0.05092  
 
Time: the number of time points when taking trait measurement.  
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Table 2.  Average type 1 error rates of the statistics for testing association of a gene that consists of all 
variants with a function quantitative trait over 5 genes.    
 Time Sample Size 0.001 0.01 0.05  
 1000 0.0014 0.0130 0.0594  
15 1500 0.0010 0.0102 0.0552  
  2000 0.0006 0.0116 0.0506  
 1000 0.0008 0.0100 0.0532  
20 1500 0.0014 0.0078 0.0490  
  2000 0.0008 0.0090 0.0418  
 1250 0.0012 0.0138 0.0544  
30 1500 0.0006 0.0092 0.0458  
  1750 0.0010 0.0076 0.0426  
 1250 0.0010 0.0126 0.0518  
40 1500 0.0008 0.0094 0.0482  
  1750 0.0008 0.0086 0.0418  
      
Time: the number of time points when taking trait measurement.  
 
Table 3. P-values of 65 genes that were significantly associated with oxygen saturation trait. 
Gene P-value Gene P-value Gene P-value 
  FLMF FLMC   FLMF FLMC   FLMF FLMC 
MAN1B1 2.53E-21 4.33E-01 GIPC1 1.93E-09 7.01E-01 CDC42EP5 7.88E-08 9.21E-01 
TMEM57 8.90E-18 8.50E-02 CDC14C 2.09E-09 1.97E-01 MIR29C 1.30E-07 9.65E-01 
OR5H15 1.28E-17 4.37E-01 MIR4520B 2.49E-09 2.64E-01 LHX2 1.95E-07 7.85E-01 
PABPC4L 2.66E-15 4.16E-01 MIR4520A 2.49E-09 9.33E-01 ZNF284 2.09E-07 9.89E-01 
ANKLE1 2.51E-14 3.31E-01 PROX2 3.63E-09 2.59E-01 RBAKDN 2.34E-07 9.63E-01 
TTI2 4.64E-14 9.27E-01 MAFF 4.04E-09 8.90E-01 BAIAP2L2 2.44E-07 2.21E-01 
KRTAP4-7 1.67E-13 2.15E-01 UQCRQ 5.95E-09 4.54E-03 P2RX5 2.92E-07 9.55E-01 
WDR90 1.73E-13 7.37E-02 LYRM1 6.58E-09 1.58E-01 P2RX5-TAX 2.92E-07 9.90E-01 
ZER1 1.67E-12 3.15E-03 ZFPM1 7.81E-09 9.58E-01 RELB 3.01E-07 7.20E-01 
DPH2 3.05E-12 8.86E-01 TMEM50B 9.59E-09 8.55E-01 TREML3P 5.42E-07 2.38E-01 
B9D2 3.43E-12 3.97E-01 KCNK15 1.78E-08 5.45E-01 TSPAN10 5.86E-07 7.50E-01 
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GGT1 4.29E-12 5.68E-01 SNORA41 1.99E-08 2.64E-01 RPS16 6.17E-07 9.75E-01 
SGSH 4.90E-12 5.86E-01 EEF1B2 1.99E-08 6.19E-01 GNLY 8.09E-07 3.99E-01 
FAM211B 1.03E-11 3.13E-01 SNORD51 1.99E-08 1.84E-01 LRRC48 8.17E-07 9.28E-01 
FBXO27 1.37E-11 3.41E-01 LDLRAP1 2.01E-08 1.50E-02 WSB1 9.64E-07 6.54E-01 
COA6 1.44E-11 8.04E-01 NEK4 2.17E-08 5.00E-01 GFPT1 1.09E-06 4.80E-01 
MAK16 2.66E-11 4.10E-01 COMMD7 2.29E-08 2.56E-01 MIR3677 1.13E-06 9.08E-02 
CDKN2AI
P 
1.69E-10 3.25E-01 EEF1A1 3.39E-08 5.44E-01 MIR940 1.13E-06 8.26E-01 
RRM2 3.07E-10 4.79E-01 MIR1-1 4.51E-08 8.76E-01 TOE1 1.13E-06 2.97E-01 
DTX3L 1.24E-09 8.80E-01 HMGN4 4.63E-08 9.24E-01 TMEM41A 2.12E-06 4.95E-01 
C17orf75 1.41E-09 2.61E-01 EVPLL 5.48E-08 8.84E-01 TPM4 2.40E-06 2.71E-01 
TAS2R5 1.72E-09 8.55E-01 C22orf26 5.60E-08 6.66E-01       
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Figure S1. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of  rare variants  in the genomic region under multiplicative 
model at the significance level, assuming a baseline penetrance of 1 and sample sizes of 1,000. 
Figure S2. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of  rare variants  in the genomic region under recessive model at 
the significance level, assuming a baseline penetrance of 1 and sample sizes of 2,000. 
Figure S3. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of  both common and rare variants  in the genomic region under 
multiplicative model at the significance level, assuming a baseline penetrance of 1 and sample 
sizes of 1,000. 
Figure S4. The power curves as a function of risk parameter of six models: the functional linear 
model with both functional response and predictors for function-valued trait (FLMF), the 
multiple linear model for function-valued trait (MLMF), the simple regression model for 
function-valued trait (SRGF), the functional linear model with scalar response and functional 
response for cross section marginal genetic model (FLMC), multiple linear model for cross 
section marginal genetic model and simple regression for cross section marginal genetic model 
(SRGC) for testing association of both and  rare variants  in the genomic region under recessive 
model at the significance level, assuming a baseline penetrance of 1 and sample sizes of 2,000. 
Figure S5. –log10 P-value of the MLM for testing the association of gene ANKLE1 with the 
oxygen saturation at each time point overnight as a function of time t  where the redline indicates 
the P-value declaring significance. 
Figure S6. –log10 P-value of the MLM for testing the association of gene TMEM50B 
 with the oxygen saturation at each time point overnight as a function of time t  where the redline 
indicates the P-value declaring significance. 
 
 Table S1. Distribution of sleep time, age and BMI    
  Male (244) Female (589) 
  Min Mean Max Min Mean Max 
Average Sleep Time 4,579 22,777 33,004 2,547 22,415 33,664 
Age 32.7 52.5 89.6 32.8 54.6 85.5 
BMI 18.7 30.7 59 20.4 32.9 60.5 
 
 Table S2. P-values of 65 significant genes calculated using 
FLMF, MFMF and SRGF. 
Gene P-value 
  FMLF MLM(min) SRG(mim) 
MAN1B1 2.53E-21 1.10E-05 6.57E-03 
TMEM57 8.90E-18 8.50E-02 3.97E-02 
OR5H15 1.28E-17 4.21E-03 3.29E-02 
PABPC4L 2.66E-15 1.09E-01 7.95E-02 
ANKLE1 2.51E-14 6.52E-07 2.98E-03 
TTI2 4.64E-14 6.82E-02 4.57E-03 
KRTAP4-7 1.67E-13 1.12E-02 5.45E-03 
WDR90 1.73E-13 1.49E-10 4.56E-04 
ZER1 1.67E-12 2.28E-03 1.42E-02 
DPH2 3.05E-12 3.09E-03 2.12E-02 
B9D2 3.43E-12 1.07E-01 2.87E-02 
GGT1 4.29E-12 7.59E-23 8.89E-03 
SGSH 4.90E-12 3.69E-04 4.42E-02 
FAM211B 1.03E-11 1.97E-23 8.89E-03 
FBXO27 1.37E-11 9.53E-03 5.00E-02 
COA6 1.44E-11 1.59E-03 2.85E-03 
MAK16 2.66E-11 3.91E-03 9.30E-03 
CDKN2AIP 1.69E-10 1.62E-01 8.54E-02 
RRM2 3.07E-10 6.14E-02 1.66E-02 
DTX3L 1.24E-09 2.41E-02 4.96E-03 
C17orf75 1.41E-09 4.38E-02 9.86E-03 
TAS2R5 1.72E-09 2.75E-01 4.57E-02 
GIPC1 1.93E-09 2.29E-02 4.41E-02 
CDC14C 2.09E-09 2.39E-04 2.40E-02 
MIR4520A 2.49E-09 1.06E-03 1.44E-01 
MIR4520B 2.49E-09 1.06E-03 1.44E-01 
PROX2 3.63E-09 5.24E-03 1.15E-02 
MAFF 4.04E-09 2.17E-03 9.18E-04 
UQCRQ 5.95E-09 1.55E-01 2.20E-02 
LYRM1 6.58E-09 1.25E-02 2.47E-03 
ZFPM1 7.81E-09 2.78E-03 9.92E-04 
TMEM50B 9.59E-09 3.14E-23 1.27E-03 
KCNK15 1.78E-08 1.19E-01 7.12E-03 
EEF1B2 1.99E-08 4.60E-03 1.08E-03 
SNORA41 1.99E-08 4.60E-03 1.08E-03 
SNORD51 1.99E-08 4.60E-03 1.08E-03 
LDLRAP1 2.01E-08 3.94E-02 2.69E-02 
NEK4 2.17E-08 3.57E-05 5.34E-05 
COMMD7 2.29E-08 1.41E-02 1.38E-02 
EEF1A1 3.39E-08 3.29E-07 1.14E-02 
MIR1-1 4.51E-08 7.91E-02 3.37E-02 
HMGN4 4.63E-08 2.05E-03 3.47E-03 
EVPLL 5.48E-08 3.53E-03 1.13E-02 
C22orf26 5.60E-08 1.17E-02 1.52E-03 
CDC42EP5 7.88E-08 4.91E-02 1.81E-02 
MIR29C 1.30E-07 2.86E-02 8.72E-03 
LHX2 1.95E-07 6.47E-03 2.77E-04 
ZNF284 2.09E-07 1.06E-01 7.87E-02 
RBAKDN 2.34E-07 2.04E-03 3.55E-04 
BAIAP2L2 2.44E-07 1.91E-02 2.14E-03 
P2RX5 2.92E-07 6.68E-03 1.62E-02 
P2RX5-TAX 2.92E-07 6.68E-03 1.62E-02 
RELB 3.01E-07 1.10E-02 1.29E-02 
TREML3P 5.42E-07 5.01E-02 4.94E-03 
TSPAN10 5.86E-07 5.43E-02 5.33E-02 
RPS16 6.17E-07 2.63E-03 6.00E-04 
GNLY 8.09E-07 1.99E-02 1.10E-02 
LRRC48 8.17E-07 1.45E-01 1.35E-02 
WSB1 9.64E-07 7.57E-03 6.63E-03 
GFPT1 1.09E-06 4.92E-12 5.56E-03 
MIR3677 1.13E-06 8.67E-02 1.40E-02 
MIR940 1.13E-06 8.67E-02 1.40E-02 
TOE1 1.13E-06 6.48E-05 6.86E-02 
TMEM41A 2.12E-06 5.98E-03 3.55E-02 
TPM4 2.40E-06 1.20E-01 8.28E-03 
 
